As primarily a public donor bank, StemCyte has supplied more than twice as
many transplants as all other family cord blood bank laboratories combined.
StemCyte has now contributed to over 1068 cord blood transplants,
and is now helping to save five to six patients per week. Most
importantly, our transplant patient outcome data demonstrates that our stem cell
units result in a very high patient survival rate. Click here to download a PDF
of our transplant Record.
Our StemCyte International Cord Blood Center laboratory is a top choice among
the world's leading transplant centers. StemCyte cord blood stem cell products
have been used by leading hospitals and transplant centers such as Duke
University, Harvard Dana Farber, Massachusetts General Hospital, John Hopkins,
Stanford, Columbia, UCLA, Singapore General, National Taiwan University,
Children's Hospital of Philadelphia, and University of Michigan among others. In
total, we have supplied cord blood units to over 200 hospitals
across 6 continents.
Our processing laboratory is one of the most licensed and accredited cord
blood banks in the world. StemCyte is not only accredited by the American
Association of Blood Banks (AABB) and is registered with the FDA, but is also
accredited by the Foundation for Accreditation of Cellular Therapy (FACT).
StemCyte Family provides families with the same stem cell viability, strict
operating procedures and extensive transplant experience as our public bank.
